Patient advocate startup Solace is set to be valued at over $300 million in new funding round from Menlo Ventures

Source: Business Insider

Juan Moyano/Getty ImagesSolace is raising a Series B funding round led by Menlo Ventures, Business Insider has learned. Solace connects patients with healthcare advocates to simplify tasks like scheduling and payments. Sources with knowledge of the deal said the new round values Solace at more than $300 million.